LarkaDrin Capsules and Omalizumab Subcutaneous
Determining the interaction of LarkaDrin Capsules and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acetaminophen / dichloralphenazone / isometheptene mucate
Brand name: Nodolor
Synonyms: n.a.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- LarkaDrin Capsules-Ombitasvir, Paritaprevir, and Ritonavir
- LarkaDrin Capsules-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- LarkaDrin Capsules-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- LarkaDrin Capsules-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- LarkaDrin Capsules-Omeclamox-Pak
- LarkaDrin Capsules-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Laronidase
- Omalizumab Subcutaneous-Laronidase Intravenous
- Omalizumab Subcutaneous-Larotrectinib
- Omalizumab Subcutaneous-Larotrectinib Capsules
- Omalizumab Subcutaneous-Larotrectinib Oral Solution
- Omalizumab Subcutaneous-Larotrectinib Sulfate